Funded Tech Companies

Volastra Therapeutics

Researching who provided funding to Volastra Therapeutics? Eli Lilly and Company, Catalio Capital Management and Polaris Partners joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Volastra Therapeutics is pioneering novel approaches to halt or prevent cancer metastasis, one of the major unsolved challenges in cancer treatment. Co-founders Lewis Cantley, Ph.D., Olivier Elemento, Ph.D. and Samuel Bakhoum, M.D., Ph.D., made seminal discoveries about the role of chromosomal instability in driving cancer spread.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/7/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Charles Hugh-Jones

        

Chief Scientific Officer

Michael Su

        

Vice President

Rumin Zhang

        

VP - Operations

Diane Tager

        

Company Investors

• Eli Lilly and Company
• Catalio Capital Management
• Polaris Partners
• Meyers Ventures
• Droia Ventures
• Arch Venture Partners
• Vida Ventures
• Cornell University
• DROIA
• Quark Venture

Browse more funded tech companies:

Volantis | Volcano

Share this article

About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary